tam - trans-aconitate 2-methyltransferase Gene

Species: Leclercia adecarboxylata (strain: USDA-ARS-USMARC-60222, nat-host: Bos taurus)

Gene Type: protein coding
Gene ID: 30332520

tam Products (2)

mRNA Protein Name
WP_059307956.1 trans-aconitate 2-methyltransferase [Leclercia adecarboxylata]
WP_059307956.1 trans-aconitate 2-methyltransferase [Leclercia adecarboxylata]
Protein Preferred Names Protein Names

trans-aconitate 2-methyltransferase

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-10227 Bortezomib 99.97% Yes
HY-50895 Gefitinib 99.99% Yes
HY-50895B Gefitinib dihydrochloride / Unkown

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-18719E Endoxifen Inhibitor 99.51% Phase 3
HY-18719B Endoxifen hydrochloride Inhibitor 98.04% Phase 3
HY-15150 Bemcentinib Inhibitor 99.92% Phase 2
HY-147218 PF-07265807 Inhibitor 95.18% Phase 1
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P99746 Murlentamab Inhibitor 95.00% Phase 2

Pre-clinical Phase

Bioactive Molecules (43)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-12494 LDC1267 Inhibitor 99.64% Unkown
HY-N3415 Kumatakenin 99.31% Unkown
HY-119039 RU-301 Inhibitor 99.75% Unkown
HY-117548 UNC1062 98.92% Unkown
HY-173268 UNC9426 Inhibitor 99.51% Unkown
HY-124066 RU-302 Inhibitor 98.72% Unkown
HY-148127 TAM558 99.48% Unkown
HY-116838 TAM-16 Inhibitor 99.13% Unkown
HY-126216 TAM-IN-2 Inhibitor 99.77% Unkown
HY-148128 TAM470 Inhibitor 95.64% Unkown
HY-P11108 RP-182 98.68% Unkown
HY-18719ES Endoxifen-d5 Inhibitor 97.52% Unkown
HY-RS13913 STIM1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-10227S Bortezomib-d8 98.0% Unkown
HY-48564 TAM558 intermediate-5 95.08% Unkown
HY-160473 TAM557 Inhibitor / Unkown
HY-160473A TAM557 TFA Inhibitor 98.52% Unkown
HY-P11108A RP-182 acetate / Unkown
HY-15150R Bemcentinib (Standard) Inhibitor 97.51% Unkown
HY-163642 TNF-α agonistic 1 98.37% Unkown
HY-10227G Bortezomib (GMP) / Unkown
HY-117008 CAY10589 Inhibitor / Unkown
HY-122601 TAM-IN-1 Inhibitor / Unkown
HY-144040 CSF1R-IN-4 / Unkown
HY-144041 CSF1R-IN-5 Inhibitor / Unkown
HY-144042 CSF1R-IN-6 / Unkown
HY-15150G Bemcentinib (GMP) Inhibitor / Unkown
HY-15150S Bemcentinib-d8 / Unkown
HY-157422 CSF1R-IN-19 Inhibitor / Unkown
HY-162415 CSF1R-IN-22 / Unkown
HY-165386 TU-100 Inhibitor / Unkown
HY-168954 CSF1R-IN-26 / Unkown
HY-173400 UNC8212 Inhibitor / Unkown
HY-184203 SM-06-09 Inhibitor / Unkown
HY-P10947 MACTIDE-V Inhibitor / Unkown
HY-P11462 UNO peptide Ligand / Unkown
HY-128776 Antitumor agent-19 Activator / Unkown
HY-169517 Protein kinase inhibitor 10 Inhibitor / Unkown
HY-400687 TAM558 intermediate-1 / Unkown
HY-400688 TAM558 intermediate-2 / Unkown
HY-400689 TAM558 intermediate-3 / Unkown
HY-400690 TAM558 intermediate-4 / Unkown
HY-RS16320 TAM Human Pre-designed siRNA Set A Pre-designed Set / Unkown
Bioactive MoleculesInhibitory Antibodies (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P99140 Anti-Mouse IL-1R Antibody (JAMA-147) Inhibitor 95.00% Unkown
HY-P99733 Mipasetamab Inhibitor 98.26% Unkown